This Biotech Has So Many Reasons to Be Liked » All About Drugs

This Biotech Has So Many Reasons to Be Liked » All About Drugs:

'via Blog this'

Galapagos Delivers Novel Osteoarthritis Molecules in Alliance with Servier » All About Drugs

Galapagos Delivers Novel Osteoarthritis Molecules in Alliance with Servier » All About Drugs:

'via Blog this'

AstraZeneca began a pivotal trial with selumetinib , thyroid cancer, Phase 3 trial » All About Drugs

AstraZeneca began a pivotal trial with selumetinib , thyroid cancer, Phase 3 trial » All About Drugs:

'via Blog this'

Mallinckrodt PLC : Mallinckrodt Pharmaceuticals Announces Positive Phase 3 Efficacy Results for MNK-795, an Extended-Release Oxycodone/Acetaminophen Combination » All About Drugs

Mallinckrodt PLC : Mallinckrodt Pharmaceuticals Announces Positive Phase 3 Efficacy Results for MNK-795, an Extended-Release Oxycodone/Acetaminophen Combination » All About Drugs:

'via Blog this'

Cytokinetics: Clinical Investigators’ Opinions On ATOMIC-AHF Trial Results « New Drug Approvals

Cytokinetics: Clinical Investigators’ Opinions On ATOMIC-AHF Trial Results « New Drug Approvals:

'via Blog this'

European Approval for Glaxos Tafinlar « New Drug Approvals

European Approval for Glaxos Tafinlar « New Drug Approvals:

'via Blog this'

HIV/AIDS vaccine passes Phase 1 clinical trial in humans « New Drug Approvals

HIV/AIDS vaccine passes Phase 1 clinical trial in humans « New Drug Approvals:

'via Blog this'